Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of innovative therapeutics that aim to improve outcomes for oncology and rare diseases. Its lead oncology product candidate is etigilimab, for patients with ad... Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of innovative therapeutics that aim to improve outcomes for oncology and rare diseases. Its lead oncology product candidate is etigilimab, for patients with advanced solid tumors. Some of the other products in the pipeline are setrusumab, alvelestat, leflutrozole, navicixizumab, and acumapimod. Show more
LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today...
Setrusumab receives Breakthrough Therapy designation from the FDA Cash of $80.5 million as of September 30, 2024, expected to fund operations into 2027 LONDON, Nov. 12, 2024 (GLOBE NEWSWIRE...
LONDON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.07 | -1.84696569921 | 3.79 | 3.82 | 3.175 | 1326113 | 3.49014801 | CS |
| 4 | -0.61 | -14.0877598152 | 4.33 | 4.42 | 3.175 | 795871 | 3.84391882 | CS |
| 12 | -0.88 | -19.1304347826 | 4.6 | 4.7999 | 3.175 | 747073 | 4.13170701 | CS |
| 26 | 0.69 | 22.7722772277 | 3.03 | 5.02 | 2.875 | 952991 | 4.00481252 | CS |
| 52 | 1.41 | 61.038961039 | 2.31 | 5.02 | 1.86 | 1122595 | 3.5302609 | CS |
| 156 | 1.71 | 85.0746268657 | 2.01 | 5.02 | 0.301 | 1420058 | 1.86051659 | CS |
| 260 | 1.17 | 45.8823529412 | 2.55 | 5.02 | 0.301 | 1254512 | 2.30716386 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
